Paul Industries delivers passivation and derouging services for biotech & bioprocessing as a single-source supplier and installer. We design, fabricate, install, passivate, and validate passivation and derouging – restoring the corrosion-resistant passive layer on stainless process systems so they stay product-contact safe and audit-ready – built to the standards your process and your auditors require.
What biotech & bioprocessing need from passivation services
Bioprocessing adds a layer of complexity beyond traditional pharma: living cell cultures, single-use and stainless hybrid trains, bioreactors, and aseptic fill-finish. Cell and gene therapy suites push classification and segregation even harder. The water, piping, and cleanroom systems supporting biologics have to protect sterility and product integrity at every step.
For this work, that means aseptic processing, single-use/stainless integration, WFI and clean steam for bioreactors, and Grade A/B cleanroom segregation – not as an afterthought, but engineered in from the first drawing.
What we deliver
- Citric and nitric acid passivation to ASTM A967 / ASTM A380 on new and existing systems
- Field passivation of installed piping, tanks, and vessels – in place, without teardown
- Rouge identification and derouging for water systems and clean-steam lines
- Before/after testing (ferroxyl, water break, copper sulfate) and full documentation packages
- Restoration of the passive chromium-oxide layer to keep 316L corrosion-resistant and product-contact safe
One accountable partner
Most biotech projects get split between an equipment supplier and an install contractor – and the validation burden falls in the gap between them. Paul Industries closes that gap by self-performing the whole scope, from supply through documented turnover.
Related: Passivation Services services · Biotech & Bioprocessing solutions · Request a quote
Frequently asked questions
What passivation services do you provide for biotech companies?
Passivation of newly fabricated spools and vessels before installation, in-situ passivation of installed piping, bioreactors, media and buffer preparation vessels and distribution loops, derouging of systems already in service, and the verification and documentation that goes with each. On biotech projects we normally sequence this as shop passivation of prefabricated sections, then a final in-situ campaign covering the tie-ins once areas are joined, because tie-in welds made after an area is treated are otherwise left with no passive film and outside every certificate issued.
Why do bioreactor systems need passivation?
A bioreactor has an unusually high density of welds and penetrations for its volume: sparger and gas inlets, agitator shaft seals, probe ports for pH, dissolved oxygen and temperature, sample valves, harvest and transfer connections. Every one of those is a weld with a chromium-depleted heat-affected zone beside it and a geometry that is harder to scour than straight pipe. Those features are also the hardest places to clean, so an unpassivated bioreactor accumulates the two problems together, surface corrosion starting exactly where cleaning is least effective.
Does passivation affect biotech process purity?
It can, and cell culture is more sensitive to this than most processes. A corroding or rouged surface releases iron, nickel and chromium into the fluid, and trace metal concentration affects cell growth rate, viability and product quality attributes such as glycosylation, at levels well below anything that would concern a piping engineer. Rouge also sheds particulate, which is a direct contamination concern in an injectable process. This is why iron in the rinse or in the process fluid is a more useful monitoring signal in biotech than surface appearance alone.
How does passivation support biotech cGMP compliance?
By producing evidence rather than an assertion. Under a cGMP quality system, the passivation of a product contact surface is an activity that has to be documented, controlled and reproducible, so what matters is the treatment record: chemistry and concentration, solution temperature, contact time, circulation method, rinse-to-target data and post-treatment verification against a named test. It also has to fit change control, since passivating an already qualified system is a change requiring assessment, and the certificate scope must be explicit about which welds and sections it covers.
Do you passivate WFI and media prep systems for biotech?
Yes, and these are the two systems that most often need it soonest. A Water for Injection loop circulating at 80 degrees C or above rouges considerably faster than an ambient system, because oxidation rate rises steeply with temperature, so the interval is commonly one to three years rather than five. Media and buffer preparation vessels present a different problem: concentrated salt solutions, frequently containing chlorides, are held warm in them, and chlorides attack the passive film directly through pitting. Both deserve boroscope inspection on a set schedule rather than treatment on failure.
Which passivation method suits biotech systems, citric or nitric?
Both meet ASTM A967. Citric is frequently chosen for biotech due to lower hazard and easier in-situ handling near sensitive operations; nitric is used where specifications call for it. Paul Industries selects per alloy and system and documents the choice.
Can you re-passivate biotech systems that have rouged?
Yes. On vessels and bioreactors the approach differs from pipework, because the constraint is proving coverage rather than achieving velocity. Chemistry has to reach the whole internal surface, including the underside of the head, behind the agitator and around internals, which means the spray device pattern must be demonstrated, normally by riboflavin coverage testing, before anyone relies on the result. Vessel derouging typically runs 2,100 to 12,000 dollars each depending on volume and internals, with heavily rouged units needing repeat cycles.
Do you passivate biotech systems during fabrication?
Yes, and doing it at fabrication stage is cheaper and more thorough than in-situ treatment alone. Shop passivation of prefabricated spools is performed by immersion with full access and easy process control, and it costs meaningfully less per foot than circulating chemistry through installed pipework. What it does not cover is the field welds that join those spools together, so a shop-passivated system still needs a final in-situ campaign after the last tie-in. Treating the two as alternatives rather than as a sequence is the mistake that leaves untreated welds in a finished system.
How do you test passivation on biotech process equipment?
Through a combination rather than any single check. ASTM A967 acceptance tests such as water immersion, high humidity, copper sulphate or the potassium ferricyanide nitric acid test demonstrate that free iron has been removed. Boroscope inspection records the actual surface condition at accessible points and, compared against baseline photographs from handover, shows whether anything is progressing. For loops, rinse water analysis for dissolved iron, conductivity and total organic carbon provides a trend that catches change before it is visible. The last of those is the most useful for ongoing monitoring.
What causes passivation failures in biotech systems?
Most failures are hydraulic or procedural rather than chemical. Insufficient flow velocity in branches and at points of use, so chemistry never properly contacts the surface there. Temperature achieved at the pump but not at the far end of the loop, which matters because citric depends on elevated temperature. Rinsing stopped on a clock rather than continued to a measured conductivity or iron target, leaving residue. Passivation performed before final tie-ins. And occasionally rinse water carrying chloride, which attacks the film that has just been formed.
Can you passivate biotech systems during a shutdown?
Yes, and in a campaign-based biotech facility the sensible move is to align the work with a planned campaign break rather than treating it as an emergency. The system must be offline throughout, and the schedule includes rinse-to-target time that cannot be rushed because the criterion is a measured value rather than elapsed hours. Build in the requalification tail as well: sampling after return to service runs on laboratory incubation, and where the affected system feeds aseptic operations a media fill may be required before production resumes.
Do you handle passivation waste safely in a biotech facility?
Yes, and working inside an operating biotech facility adds requirements beyond the chemistry itself. Temporary chemical handling has to be contained and routed so that a spill cannot reach a classified area or a drain serving one, hoses and pumps need secondary containment, and ventilation and adjacent room pressure relationships must not be disturbed while the work is underway. We agree the neutralisation point, the discharge or manifest route and the emergency response before mobilising, and we confirm with your environmental health and safety group rather than assuming the plant permit covers it.
What standards do you passivate biotech equipment to?
ASTM A967 for the chemical treatment and the acceptance tests that verify it, ASTM A380 for cleaning and descaling, and ASME BPE where the pipework is bioprocessing equipment with surface finish, drainability and documentation requirements attached. For biotech specifically, the passivation record usually also has to sit alongside the water system qualification, because the compendial monograph limits for conductivity and total organic carbon, and the endotoxin limit for Water for Injection, are what the system is ultimately judged against, and surface condition is one of the things that moves them.
Can you set up re-passivation intervals for biotech utilities?
Yes, and an evidence-based interval beats a calendar one. The approach we recommend is annual boroscope inspection at defined locations compared against baseline photographs taken at handover, supported by trending of dissolved iron, conductivity and total organic carbon in the loop. Those trends usually turn before anything is visible. Hot Water for Injection and clean steam systems typically land on a one to three year cycle, ambient purified water considerably longer. The point of trending is to schedule the campaign into a planned shutdown rather than reacting to an excursion.
How much do biotech passivation services cost?
Passivation of new installed pipework runs roughly 5 to 20 dollars per linear foot, and bioreactors and preparation vessels 2,100 to 12,000 dollars each depending on volume and internals. Derouging an operating system costs more, typically 10 to 36 dollars per linear foot for light surface rouge and 21 to 78 dollars where the oxide is adherent or embedded and repeat cycles are needed. Spray coverage verification on a vessel adds 4,800 to 22,000 dollars. Spent solution handling adds 3,500 to 22,000 dollars per campaign.
Can you passivate biotech systems nationwide?
Yes, we work nationwide from our base in Kilmarnock, Virginia. We do not operate regional branches, so we mobilise crews for planned work and confirm dates at quotation rather than promising same-day response anywhere outside our immediate area. For passivation that is rarely a constraint, because the work almost always has to be scheduled into a shutdown window anyway and the chemistry, equipment and waste arrangements need lead time to organise. Where a facility needs a same-hour response, a contractor with local presence is the better call and we will say so.
What biotech requirements do you build to?
ASME BPE for bioprocessing pipework, including SF4 electropolished product contact surfaces where compendial or biologic fluids are carried, USP monograph requirements for Purified Water and Water for Injection including the endotoxin limit that applies to WFI, and 21 CFR 211 where the facility operates under a drug quality system. Where the product is a biologic, 21 CFR 610 general biological product standards also apply. Which of these governs determines the surface finish, the verification test and the documentation, so it is worth confirming with your quality organisation before specification.
Get a single-source quote
Paul Industries designs, fabricates, installs, passivates, and validates – one accountable partner instead of a vendor plus a contractor plus a validation firm. Tell us about your project and we will scope it.
Why does biotech stainless steel need passivation?
| Requirement | What it means |
|---|---|
| Purpose | Restore corrosion resistance and prevent rouge generation in high-purity service |
| Highest-risk systems | WFI and clean steam — hot, high-purity water is aggressive to unpassivated steel |
| When required | After installation and after every subsequent weld or repair |
| Standard | ASTM A967 with ASTM A380 pre-cleaning |
| Rouge classes | Class I migratory, Class II in-situ, Class III high-temperature — each needs a different response |
| Coverage | Circulated chemistry must reach every branch; flow takes the path of least resistance |
| Verification | Documented result feeding IQ |
| Ongoing | Periodic derouging and re-passivation as part of the maintenance programme |
Do you handle validation, or just installation?
Both. For biotech passivation the documentation is the deliverable, because the treatment itself is invisible once complete. Paul Industries records the chemistry and its measured concentration, the solution temperature and how it was held across the system, the dwell time, the rinse endpoint expressed as a water quality rather than a duration, and the acceptance test result to ASTM A967 with the method named. Interior boroscope images before and after are included, because those become the baseline every future rouge inspection is judged against. Where the treated system is compendial, we support the re-sanitisation and sampling that returns it to a validated state.
Can you take a project from design through startup?
Yes. For biotech work the reason to hold fabrication and passivation together is sequencing. Shop passivation of components is worthwhile but never sufficient, because the field welds joining them and the heat-affected zones beside those welds were not covered by it, and that narrow band is exactly where corrosion and rouge begin. The expensive and common error is passivating a skid or loop before the final tie-ins are made, leaving the connecting joints as the only untreated surfaces in the system. Under one contract the order is fixed: components treated in the shop, full mechanical completion, then in-place treatment, then qualification.